Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

Savla R, Garbuzenko OB, Chen S, Rodriguez-Rodriguez L, Minko T.

Pharm Res. 2014 Dec;31(12):3487-502. doi: 10.1007/s11095-014-1436-x. Epub 2014 Jun 13.

2.

Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.

Huang H, Yue T, Xu K, Golzarian J, Yu J, Huang J.

Colloids Surf B Biointerfaces. 2015 Jul 1;131:148-54. doi: 10.1016/j.colsurfb.2015.04.047. Epub 2015 Apr 29.

PMID:
25982318
3.

Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.

Chen Y, Chen H, Zhang S, Chen F, Sun S, He Q, Ma M, Wang X, Wu H, Zhang L, Zhang L, Shi J.

Biomaterials. 2012 Mar;33(7):2388-98. doi: 10.1016/j.biomaterials.2011.11.086. Epub 2011 Dec 16.

PMID:
22177841
4.

Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson J, Zhang M.

Nanomedicine (Lond). 2008 Aug;3(4):495-505. doi: 10.2217/17435889.3.4.495.

5.

Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.

Chen TJ, Cheng TH, Chen CY, Hsu SC, Cheng TL, Liu GC, Wang YM.

J Biol Inorg Chem. 2009 Feb;14(2):253-60. doi: 10.1007/s00775-008-0445-9. Epub 2008 Oct 31.

PMID:
18975017
6.

Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.

Abbasi AZ, Prasad P, Cai P, He C, Foltz WD, Amini MA, Gordijo CR, Rauth AM, Wu XY.

J Control Release. 2015 Jul 10;209:186-96. doi: 10.1016/j.jconrel.2015.04.020. Epub 2015 Apr 20.

PMID:
25908171
7.

EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.

Patel AR, Chougule M, Singh M.

Pharm Res. 2014 Oct;31(10):2796-809. doi: 10.1007/s11095-014-1377-4. Epub 2014 May 29.

PMID:
24867421
8.

Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.

Li X, Zhao W, Liu X, Chen K, Zhu S, Shi P, Chen Y, Shi J.

Acta Biomater. 2016 Jan;30:378-87. doi: 10.1016/j.actbio.2015.11.036. Epub 2015 Nov 18.

PMID:
26602820
9.

Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.

He Y, Zhang L, Zhu D, Song C.

Int J Nanomedicine. 2014 Aug 22;9:4055-66. doi: 10.2147/IJN.S61880. eCollection 2014.

10.

Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.

Hu H, Dai A, Sun J, Li X, Gao F, Wu L, Fang Y, Yang H, An L, Wu H, Yang S.

Nanoscale. 2013 Nov 7;5(21):10447-54. doi: 10.1039/c3nr03490a. Epub 2013 Sep 13.

PMID:
24057072
11.

Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo.

Hu X, Ji Y, Wang M, Miao F, Ma H, Shen H, Jia N.

J Biomed Nanotechnol. 2013 Jun;9(6):976-84.

PMID:
23858961
12.

Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.

Felton C, Karmakar A, Gartia Y, Ramidi P, Biris AS, Ghosh A.

Drug Metab Rev. 2014 May;46(2):142-54. doi: 10.3109/03602532.2013.876429. Review.

PMID:
24754519
13.

Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.

Jie LY, Cai LL, Wang LJ, Ying XY, Yu RS, Zhang MM, Du YZ.

Int J Nanomedicine. 2012;7:3981-9. doi: 10.2147/IJN.S33593. Epub 2012 Jul 24.

14.

Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.

Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R.

J Control Release. 2011 Feb 10;149(3):314-22. doi: 10.1016/j.jconrel.2010.10.030. Epub 2010 Nov 1.

15.

A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.

Huang H, Li Y, Li C, Wang Y, Sun Y, Wang J.

Macromol Biosci. 2013 Oct;13(10):1358-68. doi: 10.1002/mabi.201300137. Epub 2013 Jul 15.

PMID:
23852809
16.

Biocompatible APTES-PEG modified magnetite nanoparticles: effective carriers of antineoplastic agents to ovarian cancer.

Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei-Zarchi S, Shahzad S.

Appl Biochem Biotechnol. 2014 May;173(1):36-54. doi: 10.1007/s12010-014-0740-6. Epub 2014 Mar 11.

PMID:
24615524
17.

Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform.

Ha TL, Kim HJ, Shin J, Im GH, Lee JW, Heo H, Yang J, Kang CM, Choe YS, Lee JH, Lee IS.

Chem Commun (Camb). 2011 Aug 28;47(32):9176-8. doi: 10.1039/c1cc12961a. Epub 2011 Jul 15.

PMID:
21761053
18.

Facile synthesis and functionalization of manganese oxide nanoparticles for targeted T1-weighted tumor MR imaging.

Luo Y, Yang J, Li J, Yu Z, Zhang G, Shi X, Shen M.

Colloids Surf B Biointerfaces. 2015 Dec 1;136:506-13. doi: 10.1016/j.colsurfb.2015.09.053. Epub 2015 Sep 30.

PMID:
26454057
19.

Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.

Athawale RB, Jain DS, Singh KK, Gude RP.

Biomed Pharmacother. 2014 Mar;68(2):231-40. doi: 10.1016/j.biopha.2014.01.004. Epub 2014 Jan 25.

PMID:
24560352
20.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
Items per page

Supplemental Content

Write to the Help Desk